Art is Her Best Friend

Yvonne is living her dream. She is an artist, dedicated to raising awareness and funds for vision research.

Driven to Find a Cure

With their son Erick affected by Leber congenital amaurosis, Drive for Sight founders, Mike and Nadine Seed, decided to combine exotic cars and community fun to fight back against blindness.

Out-pacing vision loss

Cycle for Sight founder and co-chair, Michael Ovens, will cycle any distance or run any length to help support sight-saving research.

Meet Molly Burke, FFB Youth Ambassador

Youth Ambassador

Molly Burke is a youth ambassador for the FFB, educating the public about living with blindness while delivering a message of hope to those living with vision impairment.

Meet Norma Bastidas, mom on a mission

Mom on a Mission

Norma is the second person in history to run 7 of the planet's most unforgiving environments on 7 continents in 1 year in support of vision research. Read her about incredible journey.

Meet Dale Turner, proof that research does work

Miracles do happen

Dale Turner is the first Canadian to receive an experimental treatment and have some sight restored by gene therapy. Dale is proof that investing in research works.

Research Fact Sheet ~ Stem Cell Therapy

What is a stem cell?

Many of the cells in our bodies are continually replaced by cell division. Stem cells, are one type of dividing cell, which has the ability to self-renew (generate more stem cells) or to give rise to “daughter cells” that are different from the parent (as seen below). Stem cells are present in the embryo where they divide ultimately producing all human cells. In adults, only some parts of the body retain stem cells. Consequently, many cells in our bodies are not replaced if they die - including most brain cells and the light-sensing cells of the eye called photoreceptors.

What is the goal of stem cell research in the retina?

People with retinitis pigmentosa, dry age-related macular degeneration and many other conditions, slowly lose photoreceptors. Stem cell therapy could potentially restore sight to people who have lost much of their vision by replacing the photoreceptors.

Why not transplant the retina?

Unfortunately, this doesn’t work. A donor retina surgically implanted into the eye doesn’t communicate with the brain. However research has shown that stem cells can produce photoreceptor daughters that make connections with the brain when transplanted into a host eye. Unfortunately, the eye does not welcome transplanted cells. In most studies, less than 0.01% of transplanted cells survive.

When will therapies be ready?

Stem cell transplants have restored sight to animals but there are still barriers to success in people. Scientists must be able to direct large numbers of new cells to survive and build connections, while controlling their growth to avoid causing cancers. A partnership between the FFB and the Canadian Institutes of Health Research is funding research in these areas, but it will be 10-15 years before human trials of stem cell therapy to replace photoreceptors can begin.

Where do we get stem cells for research (or therapy)?

Initially all of the cells used in research came from embryos. Today stem cells from several sources are used.

Stem Cell Source

Pros

Cons

Embryonic stem cells

- Grow and divide easily

- Can become any type of cell

- Ethical issues

- Hard to get all daughter cells to be the same

- Cells not matched to the patient

Adult stem cells such as retinal progenitor cells from the Muller glia of the eye

- Cells may be partially specialized but still able to produce different daughters

- How to control cell growth, division and differentiation is not well understood

Induced pluripotent cells are normal adult cells reprogrammed in the lab to be stem cells

- Cells can be easily gathered from the skin or mouth

- Scientist are becoming adept at controlling their growth

- Time, effort and cost to create cells

- Challenges remain to control division, and specialization

 

Could my own cells be used?

Yes, another advantage of using adult stem cells (or induced pluripotent cells) is that these cells can come from the patient. Such cells may be more likely to thrive. However if your condition is genetic, any cells taken from your body will carry the same genetic defect. Transplanted cells will begin to break down, unless other protective treatment can be used.

I have heard I can get stem cells therapy overseas. True?

Stem cell therapies have not been approved in Canada, because there is not yet enough evidence to show they are safe or effective. Treat reports of such “cures” with scepticism.

What about the new embryonic stem cell trials recently approved in the USA?

Small safety trials using embryonic stem cells to treat Stargardt’s macular degeneration (Nov 2010) and dry age-related macular degeneration (Jan 2011) have been approved in the USA. In these trials, stem cells will be used to try and restore the retinal pigment epithelium (RPE). The RPE is a layer of cells that nourishes and protects the photoreceptors in the retina. Restoring the RPE may help damaged photoreceptors survive and function more normally, but it will not replace lost vision cells.

Updated Jan 5, 2011: This text has been reviewed by Dr. Valerie Wallace of the Ottawa Hospital Research Institute and Dr. Carol Schuurmans of the University of Calgary.

See this fact sheet in PDF format

Privacy Policy | Accessibility Policy